Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Category: Uncategorized

February 19, 2021 Drug delivery / Pharma applications / Uncategorized

NIH funds study to evaluate remdesivir for COVID-19 in pregnancy

A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who

Continue reading

February 1, 2021 Uncategorized

Happy 70th Birthday, Lajos!

CycloLab celebrates birthday of L. Szente (70), former CEO Lajos Szente has been contributing to the development of the global

Continue reading

January 13, 2021 Uncategorized

Changes in the management of CycloLab

Cyclolab, a company with unparalleled expertise in the manufacturing, design and formulation of cyclodextrins, announced the appointment of Tamas Sohajda

Continue reading

January 6, 2021 Non-pharma applications / Other industrial use / Uncategorized

Use of sulfobutylether beta cyclodextrin for preparing ceramics

A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)

Continue reading

December 10, 2020 Events / Uncategorized

500th post in Cyclodextrin News blog

1986, the year of the first issue of Cyclodextrin News was abundant in notable events and new threats to be

Continue reading

November 11, 2020 Drug delivery / Non-pharma applications / Other industrial use / Pharma applications / Uncategorized

FIRST EXPERIMENTS IN SPACE FOR COVID-19 DRUG RESEARCH

The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by

Continue reading

October 21, 2020 CD as API / CD derivatives / Pharma applications / Uncategorized

New cyclodextrin with orphan drug designation: SBECD

ReVision Therapeutics, Inc., a privately-held, early stage biopharmaceutical company focused on the development and commercialization of innovative therapies for ocular

Continue reading

May 28, 2020 CD derivatives / Pharma applications / Uncategorized

UK grants early access for Gilead’s remdesivir in Covid-19

The government of the U.K. is granting the country’s equivalent to an emergency use authorization to remdesivir, the antiviral drug

Continue reading

May 22, 2020 Pharma applications / Uncategorized

First copies of Gilead’s SBECD-enabled remdesivir to start selling in Bangladesh

According to Hindustan Times, Bangladesh’s Beximco Pharmaceuticals Ltd. has become the world’s first company to start selling the generic version

Continue reading

May 8, 2020 CD derivatives / Pharma applications / Uncategorized

Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19

Japan approved the Gilead Sciences antiviral drug remdesivir Thursday for treatment of severe COVID-19 patients, under an exceptional approval pathway

Continue reading

Posts navigation

1 2 3 Next Posts»

Recent Posts

  • BIO-Europe Spring® Digital
  • HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
  • Effect of buffers on the stability of SBECD complexes
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (8)
  • Analysis (12)
  • CD as API (99)
  • CD derivatives (124)
  • Cosmetics and toilettry (10)
  • Drug delivery (191)
  • E-ducation (41)
  • Environmental (41)
  • Events (98)
  • Food (57)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (97)
  • Other industrial use (34)
  • Pharma applications (351)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • HPBCD is a unique component in Janssen's COVID-19 vaccine candidate
  • Effect of buffers on the stability of SBECD complexes
  • BIO-Europe Spring® Digital
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • The use of β-CDs to improve honey bee health
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • Cochlear spiral ganglion neuron degeneration following cyclodextrin-induced hearing loss
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Cyclo Therapeutics Announces Positive Efficacy Data in Patients with Niemann-Pick Disease Type C

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 289 other subscribers